Topics

Oxford researchers test ‘Viagra’ drug to prevent recurrent strokes

04:25 EST 16 Jan 2020 | NIHR Oxford Biomedical Research Centre

University of Oxford researchers have begun a clinical trial to assess whether the drug sildenafil, more commonly known by its commercial name Viagra, could improve blood flow to the brain and so have the potential to reduce damage to small blood vessels in the brain and prevent strokes. Chronic damage to small blood vessels deep ... Read more

The post Oxford researchers test ‘Viagra’ drug to prevent recurrent strokes appeared first on NIHR Oxford Biomedical Research Centre.

Original Article: Oxford researchers test ‘Viagra’ drug to prevent recurrent strokes

NEXT ARTICLE

More From BioPortfolio on "Oxford researchers test ‘Viagra’ drug to prevent recurrent strokes"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Erectile Dysfunction
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to 70. The causes of ED can be both physical and psycholo...